Originally published as JCO Early Release 10.1200/JCO.2005.03.3126 on June 26 2006

This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Services Email this article to a colleague Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Save to my personal folders Download to citation manager Rights & Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Andrieu, N. Articles by Goldgar, D. E. Search for Related Content PubMed PubMed Citation Articles by Andrieu, N. Articles by Goldgar, D. E. Related Articles Related Editorial Social Bookmarking                            What's this?

Effect of Chest X-Rays on the Risk of Breast Cancer Among BRCA1/2 Mutation Carriers in the International BRCA1/2 Carrier Cohort Study: A Report from the EMBRACE, GENEPSO, GEO-HEBON, and IBCCS Collaborators’ Group

Nadine Andrieu, Douglas F. Easton, Jenny Chang-Claude, Matti A. Rookus, Richard Brohet, Elisabeth Cardis, Antonis C. Antoniou, Teresa Wagner, Jacques Simard, Gareth Evans, Susan Peock, Jean-Pierre Fricker, Catherine Nogues, Laura Van't Veer, Flora E. Van Leeuwen, David E. Goldgar

From L'Institut National de la Santé et de la Recherche Médicale Emi00-06 et Service de Biostatistique de l'Institut Curie, Paris; International Agency for Research on Cancer, Lyon; Centre Paul Strauss, Strasbourg; Centre René Huguenin, Saint Cloud, France; Cancer Research UK, Genetic Epidemiology Unit, Department of Public Health and Primary Care, University of Cambridge, Cambridge; Department of Genetics, St Mary's Hospital, Manchester, United Kingdom; Division of Clinical Epidemiology, German Cancer Research Center, Heidelberg, Germany; Departments of Epidemiology and Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, the Netherlands; Division of Senology, Medical University of Vienna and Private Trust for Breast Health, Vienna, Austria; Laboratoire de Génomique des Cancers, Laval University, Québec City, Québec, Canada; and Department of Medical Informatics, University of Utah, Salt Lake City, UT; and the Gene Etude Prospective Sein Ovaire (GENEPSO), Gen en Omgeving studie van de werkgroep Hereditiair Borstkanker Onderzoek Nederland (GEO-HEBON), and the International BRCA1/2 Carrier Cohort Study (IBCCS) Collaborators’ Group

Address reprint requests to David E. Goldgar, Department of Dermatology, University of Utah School of Medicine, 30 N. Medical Dr, Salt Lake City, UT 84132; e-mail: david.goldgar{at}hsc.utah.edu

PURPOSE: Women who carry germline mutations in the BRCA1 and BRCA2 genes are at greatly increased risk of breast cancer (BC). Numerous studies have shown that moderate to high doses of ionizing radiation are a risk factor for BC. Because of the role of the BRCA proteins in DNA repair, we hypothesized that BRCA carriers might be more sensitive to ionizing radiation than women in the general population.

PATIENTS AND METHODS: A retrospective cohort study of 1,601 female BRCA1/2 carriers was performed. Risk of breast cancer from exposure to chest x-rays, as assessed by questionnaire data, was analyzed using a weighted Cox proportional hazards model.

RESULTS: In this cohort, any reported exposure to chest x-rays was associated with an increased risk of BC (hazard ratio [HR] = 1.54; P = .007). This risk was increased in carrier women aged 40 years and younger (HR = 1.97; P < .001) and in women born after 1949 (HR = 2.56; P < .001), particularly those exposed only before the age of 20 years (HR = 4.64; P < .001).

CONCLUSION: In our series of BRCA carriers, we detected a relatively large effect on BC risk with a level of radiation exposure that is at least an order of magnitude lower than in previously studied medical radiation–exposed cohorts. Although part of this increase may be attributable to recall bias, the observed patterns of risk in terms of age at exposure and attained age are consistent with those found in previous studies. If confirmed, the results have important implications for the use of x-ray imaging in young BRCA1/2 carriers.

Supported by Grants No. SI2.328176 and SPC.2002482 from the European Commission (International BRCA1/2 Carrier Cohort Study); Cancer Research UK and The British Council (Epidemiological Study of BRCA1 and BRCA2 Mutation Carriers [EMBRACE]); Fondation de France and Ligue Nationale Contre le Cancer (GENEPSO); Dutch Cancer Society Grant No. NKI98-1854 (GEO-HEBON); and the Interdisciplinary Health Research International Team on Breast Cancer Susceptibility (INHERIT) project of the Canadian Institutes of Health Research.

The funding sources providing support for the International BRCA1/2 Carrier Cohort Study had no role in the design, data collection, and analysis of the data described in this article and had no role in the writing of the article and the decision to submit the paper for publication.

Authors' disclosures of potential conflicts of interest and author contributions are found at the end of this article.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Facebook    Reddit    Technorati    Twitter    What's this?

Related Editorial

• The Case for Individualized Screening Recommendations for Breast Cancer
  Angela Bradbury and Olufumilayo I. Olopade
  JCO 2006 24: 3328-3330 [Full Text]

This article has been cited by other articles:

				F. M. Hall Mammographic Screening in Younger Women at High Risk Am. J. Roentgenol., October 1, 2009; 193(4): 1188 - 1188. [Full Text] [PDF]

				A. Berrington de Gonzalez, C. D. Berg, K. Visvanathan, and M. Robson Estimated Risk of Radiation-Induced Breast Cancer From Mammographic Screening for Young BRCA Mutation Carriers J Natl Cancer Inst, February 4, 2009; 101(3): 205 - 209. [Abstract] [Full Text] [PDF]

				A. C. Antoniou, M. Rookus, N. Andrieu, R. Brohet, J. Chang-Claude, S. Peock, M. Cook, D. G. Evans, R. Eeles, EMBRACE, et al. Reproductive and Hormonal Factors, and Ovarian Cancer Risk for BRCA1 and BRCA2 Mutation Carriers: Results from the International BRCA1/2 Carrier Cohort Study Cancer Epidemiol. Biomarkers Prev., February 1, 2009; 18(2): 601 - 610. [Abstract] [Full Text] [PDF]

				M. J. Hooning, B. M.P. Aleman, M. Hauptmann, M. H.A. Baaijens, J. G.M. Klijn, R. Noyon, M. Stovall, and F. E. van Leeuwen Roles of Radiotherapy and Chemotherapy in the Development of Contralateral Breast Cancer J. Clin. Oncol., December 1, 2008; 26(34): 5561 - 5568. [Abstract] [Full Text] [PDF]

				A N Desmond, K O'Regan, C Curran, S McWilliams, T Fitzgerald, M M Maher, and F Shanahan Crohn's disease: factors associated with exposure to high levels of diagnostic radiation Gut, November 1, 2008; 57(11): 1524 - 1529. [Abstract] [Full Text] [PDF]

				J. Russo, G. A. Balogh, I. H. Russo, and and the Fox Chase Cancer Center Hospital Network P Full-term Pregnancy Induces a Specific Genomic Signature in the Human Breast Cancer Epidemiol. Biomarkers Prev., January 1, 2008; 17(1): 51 - 66. [Abstract] [Full Text] [PDF]

				J. M. Sabate, M. Clotet, S. Torrubia, A. Gomez, R. Guerrero, P. de Las Heras, and E. Lerma Radiologic Evaluation of Breast Disorders Related to Pregnancy and Lactation RadioGraphics, October 1, 2007; 27(suppl_1): S101 - S124. [Abstract] [Full Text] [PDF]

				M. G. Andreassi, A. Cioppa, S. Manfredi, C. Palmieri, N. Botto, and E. Picano Acute chromosomal DNA damage in human lymphocytes after radiation exposure in invasive cardiovascular procedures Eur. Heart J., September 2, 2007; 28(18): 2195 - 2199. [Abstract] [Full Text] [PDF]

				R. M. Brohet, D. E. Goldgar, D. F. Easton, A. C. Antoniou, N. Andrieu, J. Chang-Claude, S. Peock, R. A. Eeles, M. Cook, C. Chu, et al. Oral Contraceptives and Breast Cancer Risk in the International BRCA1/2 Carrier Cohort Study: A Report From EMBRACE, GENEPSO, GEO-HEBON, and the IBCCS Collaborating Group J. Clin. Oncol., September 1, 2007; 25(25): 3831 - 3836. [Abstract] [Full Text] [PDF]

				K Faulkner Mammography screening and genetic disposition to radiation risk Br. J. Radiol., August 1, 2007; 80(956): 591 - 592. [Full Text] [PDF]

				D. Goldfrank, S. Chuai, J. L. Bernstein, T. Ramon y Cajal, J. B. Lee, M. C. Alonso, O. Diez, M. Baiget, N. D. Kauff, K. Offit, et al. Effect of Mammography on Breast Cancer Risk in Women with Mutations in BRCA1 or BRCA2. Cancer Epidemiol. Biomarkers Prev., November 1, 2006; 15(11): 2311 - 2313. [Abstract] [Full Text] [PDF]

				A. Bradbury and O. I. Olopade The Case for Individualized Screening Recommendations for Breast Cancer J. Clin. Oncol., July 20, 2006; 24(21): 3328 - 3330. [Full Text] [PDF]